Arvinas Arvinas is a biopharmaceutical company focused on developing protein degradation therapeutics for cancers and other diseases. | ||
Type | Type Public | Type Public |
Tags | ||
Locations | Locations South San Francisco, US HQ Bothell, US Seattle, US | Locations New Haven, US HQ |
Employees | Employees 188 | Employees 13329% increase |
Valuation ($) | Valuation ($) 243.3 m | Valuation ($) 1.9 b |
Financial | ||
Revenue (est.) | Revenue (est.) $36k (FY, 2025) | Revenue (est.) $262.6m (FY, 2025) |
Net income | Net income ($274.4m) (FY, 2025) | Net income ($80.8m) (FY, 2025) |
Arvinas is a biopharmaceutical company focused on developing protein degradation therapeutics for cancers and other diseases.
View company